Pamela A Havre

Title: Innovations of Pamela A Havre

Introduction

Pamela A Havre is a notable inventor based in Philadelphia, PA (US). She has made significant contributions to the field of biochemistry, particularly in the study of kinases and their role in cell cycle regulation. With a total of 2 patents to her name, her work has implications for understanding cancer and cell cycle control.

Latest Patents

Havre's latest patents focus on the Rec2 kinase. The invention includes a method of phosphorylating a serine-containing substrate by incubating the substrate with ATP and an enzyme that is hsRec2 or muRec2 or a derivative thereof. The natural substrates of the kinase activity of Rec2 are the cell cycle control proteins such as p53 and cyclin E. The overexpression of Rec2 is known to cause cell-cycle arrest and apoptosis, and the invention discloses that these effects are kinase-mediated. Accordingly, the invention provides a method of assessing antagonists and agonists of Rec2, which antagonists and agonists would have pharmacological activity. The invention further discloses that there is specific binding between hsRec2 and at least three cell cycle control proteins: p53, PCNA, and cdc2.

Career Highlights

Throughout her career, Pamela A Havre has demonstrated a commitment to advancing scientific knowledge in her field. Her innovative approaches to kinase research have garnered attention and respect from her peers.

Collaborations

Havre has collaborated with notable colleagues, including Michael C Rice and William K Holloman, contributing to a rich exchange of ideas and research findings.

Conclusion

Pamela A Havre's work in the field of biochemistry, particularly her patents related to Rec2 kinase, showcases her innovative spirit and dedication to scientific advancement. Her contributions are significant in the ongoing research into cell cycle control and its implications for health and disease.